WO2003095971A3 - Posh nucleic acids, polypeptides and related methods - Google Patents

Posh nucleic acids, polypeptides and related methods Download PDF

Info

Publication number
WO2003095971A3
WO2003095971A3 PCT/US2002/036366 US0236366W WO03095971A3 WO 2003095971 A3 WO2003095971 A3 WO 2003095971A3 US 0236366 W US0236366 W US 0236366W WO 03095971 A3 WO03095971 A3 WO 03095971A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
related methods
polypeptides
posh nucleic
posh
Prior art date
Application number
PCT/US2002/036366
Other languages
French (fr)
Other versions
WO2003095971A2 (en
Inventor
Iris Alroy
Tsvika Greener
Shmuel Tuvia
Danny Ben-Avraham
Original Assignee
Proteologics Inc
Iris Alroy
Tsvika Greener
Shmuel Tuvia
Danny Ben-Avraham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteologics Inc, Iris Alroy, Tsvika Greener, Shmuel Tuvia, Danny Ben-Avraham filed Critical Proteologics Inc
Priority to NZ532908A priority Critical patent/NZ532908A/en
Priority to CA2465973A priority patent/CA2465973C/en
Priority to IL16176402A priority patent/IL161764A0/en
Priority to AU2002365160A priority patent/AU2002365160C1/en
Priority to JP2004503917A priority patent/JP2005519636A/en
Priority to AU2003304109A priority patent/AU2003304109A1/en
Priority to PCT/US2003/035712 priority patent/WO2004098492A2/en
Publication of WO2003095971A2 publication Critical patent/WO2003095971A2/en
Priority to IL161764A priority patent/IL161764A/en
Publication of WO2003095971A3 publication Critical patent/WO2003095971A3/en
Priority to US11/127,559 priority patent/US20060287337A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/02—Acid—amino-acid ligases (peptide synthases)(6.3.2)
    • C12Y603/02019—Ubiquitin-protein ligase (6.3.2.19), i.e. ubiquitin-conjugating enzyme

Abstract

The application discloses novel polypeptides and nucleic acids involved in a variety of biological processes, including viral reproduction. Related methods and compositions are also described.
PCT/US2002/036366 2001-11-09 2002-11-12 Posh nucleic acids, polypeptides and related methods WO2003095971A2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
NZ532908A NZ532908A (en) 2001-11-09 2002-11-12 Posh nucleic acids, polypeptides and related methods
CA2465973A CA2465973C (en) 2001-11-09 2002-11-12 Posh nucleic acids, polypeptides and related methods
IL16176402A IL161764A0 (en) 2001-11-09 2002-11-12 Posh nucleic acids, polypeptides and related methods
AU2002365160A AU2002365160C1 (en) 2001-11-09 2002-11-12 Posh nucleic acids, polypeptides and related methods
JP2004503917A JP2005519636A (en) 2001-11-09 2002-11-12 POSH nucleic acids, polypeptides and related methods, related uses
AU2003304109A AU2003304109A1 (en) 2002-11-11 2003-11-10 Trans-golgi network-associated processes, methods and compositions related thereto
PCT/US2003/035712 WO2004098492A2 (en) 2002-11-11 2003-11-10 Trans-golgi network-associated processes, methods and compositions related thereto
IL161764A IL161764A (en) 2001-11-09 2004-05-04 Posh nucleic acids and polypeptides and uses thereof
US11/127,559 US20060287337A1 (en) 2001-11-09 2005-05-11 Trans-golgi network-associated processes, methods and compositions related thereto

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US34584601P 2001-11-09 2001-11-09
US60/345,846 2001-11-09
US36453002P 2002-03-15 2002-03-15
US60/364,530 2002-03-15

Publications (2)

Publication Number Publication Date
WO2003095971A2 WO2003095971A2 (en) 2003-11-20
WO2003095971A3 true WO2003095971A3 (en) 2005-04-28

Family

ID=26994569

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/036366 WO2003095971A2 (en) 2001-11-09 2002-11-12 Posh nucleic acids, polypeptides and related methods

Country Status (11)

Country Link
US (4) US7250250B2 (en)
EP (1) EP1310552B1 (en)
JP (1) JP2005519636A (en)
AT (1) ATE364690T1 (en)
AU (1) AU2002365160C1 (en)
CA (1) CA2465973C (en)
DE (1) DE60220621T2 (en)
HK (1) HK1055996A1 (en)
IL (2) IL161764A0 (en)
NZ (1) NZ532908A (en)
WO (1) WO2003095971A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004025708D1 (en) 2003-07-11 2010-04-08 Proteologics Inc UBIQUITIN LIGASE INHIBITORS AND RELATED METHODS
US20060188890A1 (en) * 2003-10-31 2006-08-24 Proteologics, Inc. Ubiquitin-based protein interaction assays and related compositions
AU2005295517A1 (en) * 2004-10-15 2006-04-27 Signal Pharmaceuticals, Llc P27 ubiquitination assay and methods of use
AU2005311680A1 (en) * 2004-12-01 2006-06-08 Proteologics, Inc. Ubiquitin ligase assays and related reagents
JP2008092911A (en) * 2006-10-16 2008-04-24 Univ Of Tokyo Method for detecting bonding of protein
US8614099B2 (en) 2007-08-30 2013-12-24 Mitsui Engineering & Shipbuilding Co., Ltd. FRET detection method and device
EP2346883B1 (en) 2008-09-23 2016-03-23 Scott G. Petersen Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference
WO2015023824A2 (en) * 2013-08-14 2015-02-19 The Curators Of The University Of Missouri Cell permeable inhibitors of the scaffold protein plenty of sh3 domains (posh) or sh3rfl
CN106754883B (en) * 2016-12-30 2019-10-29 中山大学 An a kind of step, seamless, non-homogeneous, multiple clips gene splicing remodeling method and its kit
CN112764372A (en) * 2020-12-25 2021-05-07 天津大学 Multi-channel signal acquisition system based on VPX framework

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002053719A2 (en) * 2001-01-04 2002-07-11 Incyte Genomics, Inc. Cytoskeleton-associated proteins
WO2002079449A2 (en) * 2001-03-28 2002-10-10 Incyte Genomics, Inc. Molecules for disease detection and treatment

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1115872A2 (en) * 1998-08-07 2001-07-18 Onyx Pharmaceuticals, Inc. Chp polypeptide, a ligand of pak65
US6511825B1 (en) * 1998-10-13 2003-01-28 Onyx Pharmaceuticals, Inc. Cell signaling polypeptides and nucleic acids
WO2000027865A1 (en) 1998-11-06 2000-05-18 The Brigham And Women's Hospital, Inc. CHARACTERIZATION OF NOVEL GENE cbl-SL
WO2001064835A2 (en) 2000-02-28 2001-09-07 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001088088A2 (en) 2000-05-18 2001-11-22 Hyseq, Inc. Novel nucleic acids and polypeptides
EP1074617A3 (en) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
AU7701100A (en) 1999-09-03 2001-04-10 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
CA2392438A1 (en) 2000-01-31 2001-08-02 Craig A. Rosen Nucleic acids, proteins, and antibodies
EP1572987A4 (en) 2000-02-03 2005-11-30 Nuvelo Inc Novel nucleic acids and polypeptides
AU2001241541A1 (en) 2000-02-17 2001-08-27 Millennium Predictive Medicine, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer
AU4592601A (en) 2000-03-21 2001-10-03 Millennium Predictive Medicine Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer
WO2001071042A2 (en) 2000-03-23 2001-09-27 Pe Corporation (Ny) Detection kits, such as nucleic acid arrays, for detecting the expression of 10,000 or more drosophila genes and uses thereof
WO2001077288A2 (en) 2000-04-06 2001-10-18 Genetics Institute, Llc. Polynucleotides encoding novel secreted proteins
WO2002024956A2 (en) 2000-09-19 2002-03-28 Whitehead Institute For Biomedical Research Genetic markers for tumors
AU2002229113A1 (en) 2000-10-20 2002-04-29 University Of Massachusetts Glucose transport-related genes and uses thereof
US20070037144A1 (en) 2000-10-20 2007-02-15 Jay Wohlgemuth Leukocyte expression profiling
AU2002241520A1 (en) 2000-11-28 2003-03-03 University Of Cincinnati Blood assessment of injury
WO2002077235A2 (en) 2000-12-21 2002-10-03 Incyte Genomics, Inc. Intracellular signaling molecules
JP2005503760A (en) 2001-01-24 2005-02-10 プロテイン デザイン ラブス， インコーポレイテッド Breast cancer diagnosis method, composition and breast cancer modulator screening method
US6743619B1 (en) 2001-01-30 2004-06-01 Nuvelo Nucleic acids and polypeptides
BR0207657A (en) 2001-02-28 2004-10-26 Chondrogene Inc One or more isolated polynucleotide sequences, vector, host cell, composition, arrangement, methods for diagnosing mild, moderate, severe and severe osteoarthritis in a patient, to identify an agent that increases or decreases the expression of a polynucleotide sequence, to prepare a chondrocyte cdna collection, and to manufacture a disposition, and set
AU2002311787A1 (en) 2001-03-28 2002-10-15 Zycos Inc. Translational profiling
WO2002085285A2 (en) 2001-04-18 2002-10-31 Wyeth Methods and reagents for regulating bone and cartilage formation
CA2447357A1 (en) 2001-05-22 2002-11-28 Gene Logic, Inc. Molecular toxicology modeling
WO2003022987A2 (en) 2001-07-26 2003-03-20 Eos Biotechnology, Inc. Methods of diagnosis of hepatitis c infection, compositions and methods of screening for modulators of hepatitis c infection
WO2003033646A2 (en) 2001-07-31 2003-04-24 Proteologics, Inc. Compositions and methods for the modulation of viral maturation
AU2002330039A1 (en) 2001-09-17 2003-04-01 Eos Biotechnology, Inc. Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
IL160905A0 (en) 2001-10-31 2004-08-31 Pfizer Prod Inc Therapeutics and diagnostics for disorders of erythropoiesis
WO2003039490A2 (en) 2001-11-09 2003-05-15 Office Of Technology Licensing Stanford University Compositions and methods for diagnosing and treating mental disorders
US20040096828A1 (en) * 2002-01-04 2004-05-20 Lu Dyung Aina M Cytoskeleton-associated proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002053719A2 (en) * 2001-01-04 2002-07-11 Incyte Genomics, Inc. Cytoskeleton-associated proteins
WO2002079449A2 (en) * 2001-03-28 2002-10-10 Incyte Genomics, Inc. Molecules for disease detection and treatment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TAPON N.: "A new Rac target POSH is an SH3-containing scaffold protein involved in the NKK and NF-kappaB signaling pathways", THE EMBO J., vol. 17, no. 5, 1998, pages 1395 - 1404, XP002250463 *

Also Published As

Publication number Publication date
DE60220621T2 (en) 2008-03-06
CA2465973A1 (en) 2003-11-20
US7429643B2 (en) 2008-09-30
US20060019240A1 (en) 2006-01-26
EP1310552A3 (en) 2003-10-08
DE60220621D1 (en) 2007-07-26
AU2002365160A1 (en) 2003-11-11
US7268227B2 (en) 2007-09-11
AU2002365160C1 (en) 2009-08-13
AU2002365160B2 (en) 2008-10-30
WO2003095971A2 (en) 2003-11-20
IL161764A0 (en) 2005-11-20
US7250250B2 (en) 2007-07-31
ATE364690T1 (en) 2007-07-15
EP1310552B1 (en) 2007-06-13
NZ532908A (en) 2008-04-30
HK1055996A1 (en) 2004-01-30
IL161764A (en) 2010-12-30
EP1310552A2 (en) 2003-05-14
US20080187538A1 (en) 2008-08-07
US20040025196A1 (en) 2004-02-05
CA2465973C (en) 2013-04-16
US20060035213A1 (en) 2006-02-16
JP2005519636A (en) 2005-07-07

Similar Documents

Publication Publication Date Title
AU2002366951A1 (en) Novel nucleic acids and polypeptides
AU2002326877A1 (en) Novel nucleic acids and polypeptides
AU2001241416A1 (en) Nucleic acids, proteins, and antibodies
AU2002343417A1 (en) Novel nucleic acids and polypeptides
WO2003029420A3 (en) Apo-2 ligand variants and uses thereof
WO2005047459A3 (en) Sars nucleic acids, proteins, antibodies, and uses thereof
AU2001244609A1 (en) Novel protein, dna thereof and process for producing the same
WO2003095971A3 (en) Posh nucleic acids, polypeptides and related methods
AU2003262789A1 (en) Abca13 nucleic acids and proteins, and uses thereof
AU2002365269A1 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
WO2005001485A3 (en) Pem-3-like compositions and related methods thereof
AU2002250254A1 (en) Nucleic acids, proteins, and antibodies
WO2003078601A3 (en) Posh nucleic acids, polypeptides and related methods
AU2002250419A1 (en) Novel nucleic acids and polypeptides
AU2002365189A1 (en) P85-alpha nucleic acids, polypeptides and related methods
WO2002102992A8 (en) Novel nucleic acids, polypeptides, methods of making, and uses thereof
AU2002365918A1 (en) Abca8 nucleic acids and proteins, and uses thereof
AU2002239056A1 (en) Novel protein, dna thereof and use of the same
AU2002335169A1 (en) Novel polypeptide, dna thereof and use of the same
AU2002335166A1 (en) Novel protein and dna thereof
AU2002226755A1 (en) Novel protein and dna thereof
AU2002335168A1 (en) Novel protein and dna thereof
AU2002228431A1 (en) Novel protein and dna thereof
AU2002344463A1 (en) Novel protein and dna thereof
AU2002306552A1 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1171/DELNP/2004

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 161764

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2465973

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002365160

Country of ref document: AU

Ref document number: 2004503917

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 532908

Country of ref document: NZ

122 Ep: pct application non-entry in european phase
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)